RARX stock - Ra Pharmaceuticals Inc

Exchange: NASDAQ

Fri 16'th Nov 2018

PERIOD 2018-08-17 - 2018-11-16
CHANGE 13.84%
PRICE $16.70
VOLUME
Buy
TREND
Buy

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Sell
Request Prediction
0.00%
Predict

Ra Pharmaceuticals Inc Stock Analysis

Technical stock analysis for Fri 16'th Nov 2018

Buy candidate since 2018-11-16
Shorts n/a
Cash n/a
Loans n/a
Beta 2.05
ROA -69.62

Ra Pharmaceuticals Inc gained 13.84% in the last trading day, rising from $14.67 to $16.70 , and has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has fallen in 6 of the last 10 days , but is still up by 10.74% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 321 016 more shares were traded than the day before. In total, 686 350 shares bought and sold for approximately $11.46 million.

Trend

Ra Pharmaceuticals Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.47% during the next 3 months and, with 90% probability hold a price between $14.47 and $24.82 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Only positive signals in the chart today. Ra Pharmaceuticals Inc holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $13.21 and $15.23. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday November 12, 2018, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 54 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Ra Pharmaceuticals Inc finds support from accumulated volume at $16.36.

Support: $16.36 Price: $16.70 Resistance: $18.06

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $2.23 between high and low, or 15.33%. For the last week, the stock has had a daily average volatility of 11.69%.

Our recommended stoploss: $15.81 (-5.30%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 4 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.

RARX $16.70 $2.03(13.84%)
RARX is up $2.03 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for RARX based on the 1-3 month system that more than doubles the S&P 500.

Click here – the RARX analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at


in partnership with